Table 1.

Patterns of methylation based on DMH and COBRA verification

Mse I cloneDMH
COBRA
T1T2T3T4T5T6T7T8T9T10T11T12T13T14T15T16T17T18T19T20TumorsTumor specific
SC22B7++++++++++++++++++
SC22B3/113++++++++++++
SC11B9***********+*
SC77F6/154**************+*
PY2B4*******+*
SC67F7/161++++++++++++++++
SC1F1.A+++++++++++++++
CPG7B8++++++++++
SC78H4+++++
CPG14C5++++++
CPG12G3++++
SC76B10/525+++++++++++
CPG5E2/359++++++
SC13H8+++++++
CPG5B3++++++++++++
CPG65G8++++++
CPG12B3/248++++++++
CPG10B3/241++++++
CPG8B5+++++++
SC90C1++++++
SC77H4++++++
CPG8B10++++++
CpG15G2/156++++++
SC70G11++++++++
SC71E3+++++
SC13D6/350++++++
SC28G11+++
SC12D7++++
SC40H7++++
SC22E5++++
SC40D10+++++
SC12B3+++++
SC77F11+++
CpG6B8++++
SC15D4+++
  • NOTE: +, hypermethylation in the tumors compared with the pooled normal endometrium control by DMH and/or by COBRA for tumors. *, methylation seen in endometrial cancers and not in normal tissues.